Chronic Use of Theophylline and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-analysis
Authors:
- Nobuyuki HoritaNHNobuyuki Horita
- Naoki MiyazawaNMNaoki Miyazawa
- Ryota KojimaRKRyota Kojima
- Miyo InoueMIMiyo Inoue
- Yoshiaki IshigatsuboYIYoshiaki Ishigatsubo
- Takeshi KanekoTKTakeshi Kaneko
- 1 May 2016
- journal article
- review article
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 52 (5) , 233-238
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Tiotropium Respimat Inhaler and the Risk of Death in COPDNew England Journal of Medicine, 2013
- Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching studyRespiratory Research, 2013
- Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonThorax, 2012
- Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trialEuropean Respiratory Journal, 2009
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary diseaseBritish Journal of Clinical Pharmacology, 2007
- Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysisRespiratory Medicine, 2005
- Comparison of the Efficacy, Tolerability, and Safety of Formoterol Dry Powder and Oral, Slow-Release Theophylline in the Treatment of COPDChest, 2002
- Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPDChest, 2001